GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.7901
-0.0117 (-1.46%)
At close: Nov 28, 2025, 4:00 PM EST
0.7852
-0.0049 (-0.62%)
After-hours: Nov 28, 2025, 4:16 PM EST
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $8.4 million as of November 28, 2025. Its market cap has increased by 9.14% in one year.
Market Cap
8.40M
Enterprise Value
6.03M
1-Year Change
9.14%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $8.40M, a decrease of -89.90%. That is a compound annual growth rate of -25.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 8.50M | 25.00% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |